NCT04711135 2026-02-12NETTER-PAdvanced Accelerator ApplicationsPhase 2 Active not recruiting11 enrolled 14 charts 1 FDA
NCT02658968 2024-01-16Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)Nordic NanovectorPhase 1 Completed18 enrolled 16 charts